Natural Products' Role Against COVID-19

Overview

Journal RSC Adv

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2022 Jun 13

PMID 35693131

Authors

Ananda da Silva Antonio

Larissa Silveira Moreira Wiedemann

Valdir Florencio Veiga-Junior

Affiliations

Soon will be listed here.

Abstract

COVID-19 is a viral disease caused by a new severe acute respiratory syndrome (SARS-CoV-2), which has quickly resulted in a pandemic. As a great threat to global public health, the development of a treatment has become vital, and a rush to find a cure has mobilized researchers from all areas across the world. Synthetic drugs, such as hydroxychloroquine, have gained attention. However, the efficacy of repositioned drugs is still under evaluation, and besides, some severe side effects are a cause for concern. This emphasizes the urgency for treatment options, which can be both safe and effective. With this in mind, natural products could be an important resource in the development of COVID-19 treatment, as they have already contributed in the past to treatments against other viruses, such as HIV, MERS-CoV, and influenza. Natural products are described long term as bioactive substances and some phytochemical classes such as flavonoids, alkaloids, and peptides are known antiviral bioproducts, and have been virtually tested with success against COVID-19. However, important issues still need to be addressed as to their bioavailability and true efficacy . This review intends to systematically evaluate the natural metabolites that could potentially be used against this new disease looking at their natural sources, mechanism of action and previous pharmacological usages. The aim is to provide a starting point for this research area in order to speed up the establishment of anti-SARS-CoV-2 bioproducts.

Citing Articles

3D Printing of Virucidal Polymer Nanocomposites (PLA/Copper Nanoparticles).

Silva Dias W, Demosthenes L, Costa J, Pocrifka L, Reis do Nascimento N, Coelho Pinheiro S Polymers (Basel). 2025; 17(3).

PMID: 39940486 PMC: 11819759. DOI: 10.3390/polym17030283.

Inhibiting SARS-CoV-2 viral entry by targeting spike:ACE2 interaction with -modified quercetin derivatives.

Rosal R, Paderes M RSC Med Chem. 2024; .

PMID: 39165908 PMC: 11331306. DOI: 10.1039/d4md00286e.

Drug repositioning identifies salvinorin A and deacetylgedunin (DCG) enriched plant extracts as novel inhibitors of Mpro, RBD-ACE2 and TMPRRS2 proteins.

Shayo M, Samwel B, Shadrack D, Cassel J, Salvino J, Montaner L RSC Adv. 2024; 14(29):21203-21212.

PMID: 38966817 PMC: 11223729. DOI: 10.1039/d4ra02593h.

Set of data on consumers' perceived safety and efficacy towards natural health products to control or cure Covid-19 viruses in Malaysia.

Mustafa Din W, Arham A, Md Yusoff Y Data Brief. 2024; 54:110548.

PMID: 38912420 PMC: 11190492. DOI: 10.1016/j.dib.2024.110548.

Marine-Derived Bioactive Metabolites as a Potential Therapeutic Intervention in Managing Viral Diseases: Insights from the SARS-CoV-2 In Silico and Pre-Clinical Studies.

Okechukwu Q, Adepoju F, Kanwugu O, Adadi P, Serrano-Aroca A, Uversky V Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543114 PMC: 10975954. DOI: 10.3390/ph17030328.

References

Gentile D, Patamia V, Scala A, Sciortino M, Piperno A, Rescifina A . Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study. Mar Drugs. 2020; 18(4). PMC: 7231030. DOI: 10.3390/md18040225. View

Wen C, Kuo Y, Jan J, Liang P, Wang S, Liu H . Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem. 2007; 50(17):4087-95. DOI: 10.1021/jm070295s. View

Rahman N, Basharat Z, Yousuf M, Castaldo G, Rastrelli L, Khan H . Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2). Molecules. 2020; 25(10). PMC: 7287752. DOI: 10.3390/molecules25102271. View

Lee S, Hur S . Antihypertensive peptides from animal products, marine organisms, and plants. Food Chem. 2017; 228:506-517. DOI: 10.1016/j.foodchem.2017.02.039. View

Rice G, Thomas D, Grant P, Turner A, Hooper N . Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J. 2004; 383(Pt 1):45-51. PMC: 1134042. DOI: 10.1042/BJ20040634. View

Dhama K, Sharun K, Tiwari R, Dadar M, Singh Malik Y, Singh K . COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccin Immunother. 2020; 16(6):1232-1238. PMC: 7103671. DOI: 10.1080/21645515.2020.1735227. View

Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr H . Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003; 361(9374):2045-6. PMC: 7112442. DOI: 10.1016/s0140-6736(03)13615-x. View

Gazak R, Walterova D, Kren V . Silybin and silymarin--new and emerging applications in medicine. Curr Med Chem. 2007; 14(3):315-38. DOI: 10.2174/092986707779941159. View

Guan L, Yang H, Cai Y, Sun L, Di P, Li W . ADMET-score - a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm. 2019; 10(1):148-157. PMC: 6350845. DOI: 10.1039/c8md00472b. View

10.

Yang Y, Islam M, Wang J, Li Y, Chen X . Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective. Int J Biol Sci. 2020; 16(10):1708-1717. PMC: 7098036. DOI: 10.7150/ijbs.45538. View

11.

Denaro M, Smeriglio A, Barreca D, De Francesco C, Occhiuto C, Milano G . Antiviral activity of plants and their isolated bioactive compounds: An update. Phytother Res. 2019; 34(4):742-768. DOI: 10.1002/ptr.6575. View

12.

Daskaya-Dikmen C, Yucetepe A, Karbancioglu-Guler F, Daskaya H, Ozcelik B . Angiotensin-I-Converting Enzyme (ACE)-Inhibitory Peptides from Plants. Nutrients. 2017; 9(4). PMC: 5409655. DOI: 10.3390/nu9040316. View

13.

Lin L, Hsu W, Lin C . Antiviral natural products and herbal medicines. J Tradit Complement Med. 2014; 4(1):24-35. PMC: 4032839. DOI: 10.4103/2225-4110.124335. View

14.

Costa da Silveira Oliveira A, Ricardo Teixeira R, Silva de Oliveira A, de Souza A, da Silva M, de Paula S . Potential Antivirals: Natural Products Targeting Replication Enzymes of Dengue and Chikungunya Viruses. Molecules. 2017; 22(3). PMC: 6155337. DOI: 10.3390/molecules22030505. View

15.

Islam M, Sarkar C, El-Kersh D, Jamaddar S, Uddin S, Shilpi J . Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data. Phytother Res. 2020; 34(10):2471-2492. DOI: 10.1002/ptr.6700. View

16.

Zhang H, Penninger J, Li Y, Zhong N, Slutsky A . Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020; 46(4):586-590. PMC: 7079879. DOI: 10.1007/s00134-020-05985-9. View

17.

Li S, Chen C, Zhang H, Guo H, Wang H, Wang L . Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005; 67(1):18-23. PMC: 7114104. DOI: 10.1016/j.antiviral.2005.02.007. View

18.

Tsai Y, Lee C, Yen H, Chang Y, Lin Y, Huang S . Antiviral Action of Tryptanthrin Isolated from Leaf against Human Coronavirus NL63. Biomolecules. 2020; 10(3). PMC: 7175275. DOI: 10.3390/biom10030366. View

19.

Shen L, Mao H, Wu Y, Tanaka Y, Zhang W . TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections. Biochimie. 2017; 142:1-10. PMC: 7116903. DOI: 10.1016/j.biochi.2017.07.016. View

20.

da Silva J, Figueiredo P, Byler K, Setzer W . Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS-CoV-2 Infection: An Investigation. Int J Mol Sci. 2020; 21(10). PMC: 7279430. DOI: 10.3390/ijms21103426. View